SignatureFD’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-235
| Closed | -$714 | – | 3476 |
|
|
2024
Q4 | $714 | Buy |
235
+144
| +158% | +$438 | ﹤0.01% | 3078 |
|
|
2024
Q3 | $472 | Sell |
91
-12
| -12% | -$62 | ﹤0.01% | 3097 |
|
|
2024
Q2 | $265 | Sell |
103
-458
| -82% | -$1.18K | ﹤0.01% | 3034 |
|
|
2024
Q1 | $2.76K | Buy |
561
+104
| +23% | +$512 | ﹤0.01% | 2705 |
|
|
2023
Q4 | $4.02K | Sell |
457
-381
| -45% | -$3.35K | ﹤0.01% | 2564 |
|
|
2023
Q3 | $9.61K | Sell |
838
-555
| -40% | -$6.37K | ﹤0.01% | 2222 |
|
|
2023
Q2 | $35.3K | Hold |
1,393
| – | – | ﹤0.01% | 1604 |
|
|
2023
Q1 | $44.9K | Buy |
1,393
+1,237
| +793% | +$39.8K | ﹤0.01% | 1450 |
|
|
2022
Q4 | $2.88K | Sell |
156
-91
| -37% | -$1.68K | ﹤0.01% | 2675 |
|
|
2022
Q3 | $7K | Buy |
247
+138
| +127% | +$3.91K | ﹤0.01% | 2290 |
|
|
2022
Q2 | $2K | Buy |
109
+24
| +28% | +$440 | ﹤0.01% | 2824 |
|
|
2022
Q1 | $2K | Sell |
85
-275
| -76% | -$6.47K | ﹤0.01% | 2878 |
|
|
2021
Q4 | $6K | Buy |
360
+294
| +445% | +$4.9K | ﹤0.01% | 2359 |
|
|
2021
Q3 | $2K | Sell |
66
-15
| -19% | -$455 | ﹤0.01% | 2723 |
|
|
2021
Q2 | $2K | Buy |
81
+15
| +23% | +$370 | ﹤0.01% | 2627 |
|
|
2021
Q1 | $2K | Hold |
66
| – | – | ﹤0.01% | 2543 |
|
|
2020
Q4 | $2K | Hold |
66
| – | – | ﹤0.01% | 2325 |
|
|
2020
Q3 | $2K | Hold |
66
| – | – | ﹤0.01% | 2285 |
|
|
2020
Q2 | $2K | Hold |
66
| – | – | ﹤0.01% | 2202 |
|
|
2020
Q1 | $1K | Hold |
66
| – | – | ﹤0.01% | 2211 |
|
|
2019
Q4 | $1K | Hold |
66
| – | – | ﹤0.01% | 2119 |
|
|
2019
Q3 | $1K | Hold |
66
| – | – | ﹤0.01% | 2032 |
|
|
2019
Q2 | $1K | Buy |
+66
| New | +$1K | ﹤0.01% | 1970 |
|